{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "p.A244G",
        "Protein_Change": {
          "ref": "L",
          "alt": "R",
          "position": "858"
        },
        "variant_string_id": "p.A244G L858R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "These mutations block wild-type PINK1's protective effect against staurosporine-induced apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that the mutations disrupt PINK1's function in a pathogenic manner."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The functional assay models PINK1's role in apoptosis pathways.",
          "judgment": "Yes",
          "reasoning": "The paper references standard techniques used in such assays."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Both mutations were tested in cell models and in the same context.",
          "judgment": "No",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Both variants show clear pathogenic effects.",
          "judgment": "Yes",
          "reasoning": "The paper directly supports the pathogenicity of the mutations."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "Both mutations demonstrate pathogenicity in PINK1-related parkinsonism, supporting their classification as very strong pathogenic variants."
    },
    {
      "variant_id": {
        "Gene": "p.V317I",
        "Protein_Change": {
          "ref": "V",
          "alt": "I",
          "position": "117"
        },
        "variant_string_id": "p.V317I V117I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "These mutations impair PINK1's protective role in apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states that the mutations disrupt PINK1's function in a pathogenic manner."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The functional assay models PINK1's role in apoptosis pathways.",
          "judgment": "Yes",
          "reasoning": "The paper references standard techniques used in such assays."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Both mutations were tested in cell models and in the same context.",
          "judgment": "No",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Both variants show clear pathogenic effects.",
          "judgment": "Yes",
          "reasoning": "The paper directly supports the pathogenicity of the mutations."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "Both mutations demonstrate pathogenicity in PINK1-related parkinsonism, supporting their classification as very strong pathogenic variants."
    }
  ]
}